These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of pharmacokinetics and toxicity after high-dose methotrexate treatments in children with acute lymphoblastic leukemia. Csordas K, Hegyi M, Eipel OT, Muller J, Erdelyi DJ, Kovacs GT. Anticancer Drugs; 2013 Feb; 24(2):189-97. PubMed ID: 23187460 [Abstract] [Full Text] [Related]
4. High-dose methotrexate therapy of childhood acute lymphoblastic leukemia: lack of relation between serum methotrexate concentration and creatinine clearance. Joannon P, Oviedo I, Campbell M, Tordecilla J. Pediatr Blood Cancer; 2004 Jul; 43(1):17-22. PubMed ID: 15170885 [Abstract] [Full Text] [Related]
5. Creatinine clearance rate and serum creatinine concentration are related to delayed methotrexate elimination in children with lymphoblastic malignancies. Mao J, Zhang L, Shen H, Tang Y, Song H, Zhao F, Xu W. Neoplasma; 2014 Jul; 61(1):77-82. PubMed ID: 24195512 [Abstract] [Full Text] [Related]
6. [Correlation study of blood drug concentration and nephrotoxicity on high dose methotrexate therapy in suggestion of diagnosis and treatment of childhood acute lymphoblastic leukemia in the 4th revised edition]. Cheng DH, Lu H, Zou XQ. Zhonghua Er Ke Za Zhi; 2017 Oct 02; 55(10):771-774. PubMed ID: 29050116 [Abstract] [Full Text] [Related]
8. [Relationship between the methylenetetrahydrofolate reductase gene polymorphism and adverse reactions of high-dose methotrexate in children with acute lymphocytic leukemia]. Zheng MM, Yue LJ, Chen XW, Wen FQ, Li CG, Yang CL, Xie C, Ding H. Zhongguo Dang Dai Er Ke Za Zhi; 2013 Mar 02; 15(3):201-6. PubMed ID: 23498762 [Abstract] [Full Text] [Related]
10. Retrospective study on elimination delay of methotrexate in high-dose therapy of childhood acute lymphoblastic leukemia in China. Xu W, Tang Y, Song H, Shi S, Yang S. J Pediatr Hematol Oncol; 2007 Oct 02; 29(10):688-93. PubMed ID: 17921849 [Abstract] [Full Text] [Related]
12. [Efficacy, side effects and blood concentration monitoring of high-dose methotrexate in treatment of 180 children with acute lymphoblastic leukemia]. Wang H, Chi ZF, Li S, Wang XL, Hao LC. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug 02; 19(4):949-52. PubMed ID: 21867621 [Abstract] [Full Text] [Related]
13. Serum creatinine and creatinine clearance for predicting plasma methotrexate concentrations after high-dose methotrexate chemotherapy for the treatment for childhood lymphoblastic malignancies. Xu WQ, Zhang LY, Chen XY, Pan BH, Mao JQ, Song H, Li JY, Tang YM. Cancer Chemother Pharmacol; 2014 Jan 02; 73(1):79-86. PubMed ID: 24158402 [Abstract] [Full Text] [Related]
14. Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate. Spiegler BJ, Kennedy K, Maze R, Greenberg ML, Weitzman S, Hitzler JK, Nathan PC. J Clin Oncol; 2006 Aug 20; 24(24):3858-64. PubMed ID: 16921038 [Abstract] [Full Text] [Related]